{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T08:14:30Z","timestamp":1778314470873,"version":"3.51.4"},"reference-count":42,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,6]]},"DOI":"10.1097\/fpc.0b013e3282f85e26","type":"journal-article","created":{"date-parts":[[2008,5,4]],"date-time":"2008-05-04T06:21:15Z","timestamp":1209882075000},"page":"449-457","source":"Crossref","is-referenced-by-count":37,"title":["BDNF gene is a genetic risk factor for schizophrenia and is related to the chlorpromazine-induced extrapyramidal syndrome in the Chinese population"],"prefix":"10.1097","volume":"18","author":[{"given":"Ming-Qing","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"St Clair","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo-Yin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhi-Guang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guang","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingwang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"He","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210212","first-page":"336","article-title":"Genetics of schizophrenia: from animal models to clinical studies","volume":"27","author":"Joober","year":"2002","journal-title":"J Psychiatry Neurosci"},{"key":"R2-1-20210212","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0031-6997(24)01483-2","article-title":"Antipsychotic drugs: importance of dopamine receptors for mechanisms of therapeutic actions and side effects","volume":"53","author":"Strange","year":"2001","journal-title":"Pharmacol Rev"},{"key":"R3-1-20210212","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0092-8674(03)00035-7","article-title":"The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function","volume":"112","author":"Egan","year":"2003","journal-title":"Cell"},{"key":"R4-1-20210212","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1038\/sj.mp.4001308","article-title":"Reduced brain-derived neurotrophic factor in prefrontal cortex of patients with schizophrenia","volume":"8","author":"Weickert","year":"2003","journal-title":"Mol Psychiatry"},{"key":"R5-1-20210212","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/1098-2396(20010101)39:1<70::AID-SYN10>3.0.CO;2-J","article-title":"Changes in the pattern of brain-derived neurotrophic factor immunoreactivity in the rat brain after acute and subchronic haloperidol treatment","volume":"39","author":"Dawson","year":"2001","journal-title":"Synapse"},{"key":"R6-1-20210212","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1002\/jnr.10609","article-title":"Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-D-aspartate receptor activity","volume":"72","author":"Fumagalli","year":"2003","journal-title":"J Neurosci Res"},{"key":"R7-1-20210212","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/1.5.353-a","article-title":"Dinucleotide repeat polymorphism at the human gene for the brain-derived neurotrophic factor (BDNF)","volume":"1","author":"Proschel","year":"1992","journal-title":"Hum Mol Genet"},{"key":"R8-1-20210212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/10290","article-title":"Characterization of single nucleotide polymorphisms in coding regions of human genes","volume":"22","author":"Cargill","year":"1999","journal-title":"Nat Genet"},{"key":"R9-1-20210212","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/sj.mp.4000749","article-title":"Brain derived neurotrophic factor (BDNF) gene variants association with age at onset and therapeutic response in schizophrenia","volume":"5","author":"Krebs","year":"2000","journal-title":"Mol Psychiatry"},{"key":"R10-1-20210212","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0165-1781(98)00076-6","article-title":"No linkage or linkage disequilibrium between brain-derived neurotrophic factor (BDNF) dinucleotide repeat polymorphism and schizophrenia in Irish families","volume":"81","author":"Hawi","year":"1998","journal-title":"Psychiatry Res"},{"key":"R11-1-20210212","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0920-9964(00)00106-7","article-title":"Association study of schizophrenia with polymorphisms at six candidate genes","volume":"49","author":"Virgos","year":"2001","journal-title":"Schizophr Res"},{"key":"R12-1-20210212","doi-asserted-by":"crossref","first-page":"6690","DOI":"10.1523\/JNEUROSCI.23-17-06690.2003","article-title":"Brainderived neurotrophic factor val66met polymorphism affects human memory-related hippocampal activity and predicts memory performance","volume":"23","author":"Hariri","year":"2003","journal-title":"J Neurosci"},{"key":"R13-1-20210212","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1001\/archpsyc.63.7.731","article-title":"Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers","volume":"63","author":"Ho","year":"2006","journal-title":"Arch Gen Psychiatry"},{"key":"R14-1-20210212","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/sj.mp.4001575","article-title":"BDNF gene is a risk factor for schizophrenia in a Scottish population","volume":"10","author":"Neves-Pereira","year":"2005","journal-title":"Mol Psychiatry"},{"key":"R15-1-20210212","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0304-3940(03)00828-0","article-title":"An association study of a brain-derived neurotrophic factor Val66Met polymorphism and clozapine response of schizophrenic patients","volume":"349","author":"Hong","year":"2003","journal-title":"Neurosci Lett"},{"key":"R16-1-20210212","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1385\/NMM:5:3:243","article-title":"Association analysis of the dopamine D3 receptor gene ser9gly and brain-derived neurotrophic factor gene val66met polymorphisms with antipsychotic-induced persistent tardive dyskinesia and clinical expression in Chinese schizophrenic patients","volume":"5","author":"Liou","year":"2004","journal-title":"Neuromolecular Med"},{"key":"R17-1-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2006.02.054","article-title":"Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism in schizophrenia is associated with age at onset and symptoms","volume":"401","author":"Numata","year":"2007","journal-title":"Neurosci Lett"},{"key":"R18-1-20210212","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1080\/15622970410029936","article-title":"Association analysis of brain-derived neurotrophic factor (BDNF) gene Val66Met polymorphism in schizophrenia and bipolar affective disorder","volume":"5","author":"Skibinska","year":"2004","journal-title":"World J Biol Psychiatry"},{"key":"R20-1-20210212","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00406-004-0560-8","article-title":"Interaction of tumor necrosis alpha-G308A and epidermal growth factor gene polymorphisms in early-onset schizophrenia","volume":"255","author":"Kampman","year":"2005","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"R21-1-20210212","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0920-9964(03)00015-X","article-title":"Psychopathology of early-onset versus late-onset schizophrenia revisited: an observation of 473 neuroleptic-naive patients before and after first-admission treatments","volume":"67","author":"Sato","year":"2004","journal-title":"Schizophr Res"},{"key":"R22-1-20210212","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1176\/ajp.152.5.722","article-title":"Clinical and neuropsychological characteristics of patients with late-onset schizophrenia","volume":"152","author":"Jeste","year":"1995","journal-title":"Am J Psychiatry"},{"key":"R23-1-20210212","first-page":"43","article-title":"Search for the causes of schizophrenia","author":"Hafner","year":"1995"},{"key":"R24-1-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2004.11.014","article-title":"Response to chlorpromazine treatment may be associated with polymorphisms of the DRD2 gene in Chinese schizophrenic patients","volume":"376","author":"Wu","year":"2005","journal-title":"Neurosci Lett"},{"key":"R25-1-20210212","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1001\/archpsyc.1988.01800330013001","article-title":"Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine","volume":"45","author":"Kane","year":"1988","journal-title":"Arch Gen Psychiatry"},{"key":"R27-1-20210212","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The brief psychiatric rating scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychol Rep"},{"key":"R28-1-20210212","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.4088\/JCP.v68n0906","article-title":"Association of AKT1 gene polymorphisms with risk of schizophrenia and with response to antipsychotics in the Chinese population","volume":"68","author":"Xu","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"R29-1-20210212","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0165-1781(99)00114-6","article-title":"Use of BPRS-A percent change scores to identify significant clinical improvement: accuracy of treatment response classification in acute psychiatric inpatients","volume":"89","author":"Lachar","year":"1999","journal-title":"Psychiatry Res"},{"key":"R30-1-20210212","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/sj.mp.4001054","article-title":"Relationship between adverse effects of antipsychotic treatment and dopamine D(2) receptor polymorphisms in patients with schizophrenia","volume":"7","author":"Kaiser","year":"2002","journal-title":"Mol Psychiatry"},{"key":"R31-1-20210212","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1177\/0269881106062894","article-title":"The influence of the CYP2D6 polymorphism on psychopathological and extrapyramidal symptoms in the patients on long-term antipsychotic treatment","volume":"20","author":"Kores Plesnicar","year":"2006","journal-title":"J Psychopharmacol"},{"issue":"Suppl","key":"R32-1-20210212","doi-asserted-by":"crossref","first-page":"35S","DOI":"10.1016\/0893-133X(95)00203-P","article-title":"Extrapyramidal symptoms during long-term treatment with antipsychotics: special focus on clozapine and D1 and D2 dopamine antagonists","volume":"14","author":"Gerlach","year":"1996","journal-title":"Neuropsychopharmacology"},{"key":"R33-1-20210212","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1471-2377-5-5","article-title":"Validity of Simpson-Angus Scale (SAS) in a naturalistic schizophrenia population","volume":"5","author":"Janno","year":"2005","journal-title":"BMC Neurol"},{"key":"R34-1-20210212","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1093\/bioinformatics\/bth071","article-title":"2LD, Genecounting and HAP: computer programs for linkage disequilibrium analysis","volume":"20","author":"Zhao","year":"2004","journal-title":"Bioinformatics"},{"key":"R35-1-20210212","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/319501","article-title":"A new statistical method for haplotype reconstruction from population data","volume":"68","author":"Stephens","year":"2001","journal-title":"Am J Hum Genet"},{"key":"R36-1-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3758\/BF03203630","article-title":"G*Power: a general power analysis program","volume":"28","author":"Erdfelder","year":"1996","journal-title":"Behav Res Methods Instrum Comput"},{"key":"R37-1-20210212","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1086\/379928","article-title":"The DTNBP1 (dysbindin) gene contributes to schizophrenia, depending on family history of the disease","volume":"73","author":"van Den Bogaert","year":"2003","journal-title":"Am J Hum Genet"},{"key":"R38-1-20210212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/YPG.0b013e32801119da","article-title":"Brain-derived neurotrophic factor gene polymorphisms and schizophrenia: a meta-analysis","volume":"17","author":"Zintzaras","year":"2007","journal-title":"Psychiatr Genet"},{"key":"R39-1-20210212","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/sj.mp.4001817","article-title":"Association of the NRG1 gene and schizophrenia: a meta-analysis","volume":"11","author":"Munafo","year":"2006","journal-title":"Mol Psychiatry"},{"key":"R40-1-20210212","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0065-2660(01)42023-2","article-title":"The future of genetic case-control studies","volume":"42","author":"Schork","year":"2001","journal-title":"Adv Genet"},{"key":"R41-1-20210212","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/nature04226","article-title":"A haplotype map of the human genome","volume":"437","author":"Altshuler","year":"2005","journal-title":"Nature"},{"key":"R42-1-20210212","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/sj.mp.4002009","article-title":"Pharmacogenetics and pharmacogenomics of schizophrenia: a review of last decade of research","volume":"12","author":"Arranz","year":"2007","journal-title":"Mol Psychiatry"},{"key":"R43-1-20210212","doi-asserted-by":"crossref","first-page":"e07","DOI":"10.4088\/JCP.0806e07","article-title":"Schizophrenia: a neurodevelopmental or a neurodegenerative disorder","volume":"67","author":"Malaspina","year":"2006","journal-title":"J Clin Psychiatry"},{"key":"R44-1-20210212","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/35075076","article-title":"BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization","volume":"411","author":"Guillin","year":"2001","journal-title":"Nature"}],"container-title":["Pharmacogenetics and Genomics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/01213011-200806000-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T01:23:42Z","timestamp":1738200222000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01213011-200806000-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6]]},"references-count":42,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/fpc.0b013e3282f85e26","relation":{},"ISSN":["1744-6872"],"issn-type":[{"value":"1744-6872","type":"print"}],"subject":[],"published":{"date-parts":[[2008,6]]}}}